References
- JeschkeMGChinkesDLFinnertyCCPathophysiologic response to severe burn injuryAnn Surg200824838740118791359
- AvniTLevcovichAAd-ElDDLeiboviciLPaulMProphylactic antibiotics for burns patients: systematic review and meta-analysisBMJ2010340c24120156911
- GaleanoMAltavillaDCucinottaDRecombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouseDiabetes2004532509251715331568
- SorgHKruegerCSchulzTMengerMDSchmitzFVollmarBEffects of erythropoietin in skin wound healing are dose relatedFASEB J2009233049305819403513
- HamedSUllmannYMasoudMHellouEKhamaysiZTeotLTopical erythropoietin promotes wound repair in diabetic ratsJ Invest Dermatol201013028729419626038
- BaderALorenzKRichterAInteractive role of trauma cytokines and erythropoietin and their therapeutic potential for acute and chronic woundsRejuvenation Res201114576621329452
- ParganasEWangDStravopodisDJak2 is essential for signalling through a variety of cytokine receptorsCell1998933853959590173
- BodóEKrommingaAFunkWHuman hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietinFASEB J2007213346335417540710
- JelkmannWMolecular biology of erythropoietinIntern Med2004864965915468961
- BrinesMGrassoGFiordalisoFErythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptorProc Natl Acad Sci U S A2004101149071491215456912
- BrinesMCeramiAErythropoietin mediated tissue protection: reducing collateral damage from the primary injury responseJ Intern Med200826440543219017170
- JelkmannWBohliusJHallekMSytkowskiAJThe erythropoietin receptor in normal and cancer tissuesCrit Rev Oncol Hematol200867396118434185
- ScottCLRobbLPapaevangeliouBMansfieldRNicolaNABegleyCGReassessment of interactions between hematopoietic receptors using common beta-chain and interleukin-3-specific receptor beta-chain-null cells: no evidence of functional interactions with receptors for erythropoietin, granulocyte colony stimulating factor, or stem cell factorBlood2000961588159010942411
- LeBaronMJAhonenTJNevalainenMTRuiHIn vivo response-based identification of direct hormone target cell populations using high-density tissue arraysEndocrinology2007148989100817138649
- GaleanoMAltavillaDBittoARecombinant human erythropoietin improves angiogenesis and wound healing in experimental burn woundsCrit Care Med2006341139114616484928
- SaqibNDulinLKrierKHowdieshellTRTemporal and spatial expression of erythropoietin, erythropoietin receptor, and common β receptor in wound fluid and granulationWounds2009217
- LorenzKSickerMSchmelzerEMultilineage differentiation potential of human dermal skin-derived fibroblastsExp Dermatol20081192593218557932
- HerndonDNHawkinsHKNguyenTTPierreECoxRBarrowRECharacterization of growth hormone enhanced donor site healing in patients with large cutaneous burnsAnn Surg19952216496567794069
- ElliottSBusseLBassMBAnti-Epo receptor antibodies do not predict Epo receptor expressionBlood20061071892189516249375
- PausRBodóEKrommingaAJelkmannWErythropoietin and the skin: a role for epidermal oxygen sensingBioessays20093134434819260015
- CohanRAMadadkar-SobhaniAKhanahmadHDesign, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietinInt J Nanomedicine201161217122721753873
- CheethamJCSmithDMAokiKHNMR structure of human erythropoietin and a comparison with its receptor bound conformationNat Struct Biol199858618669783743
- WangTHuYLeachMKErythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalaciaInt J Pharm201242246247122101293
- KhachanePDateAANagarsenkerMSEudragit EPO nanoparticles: application in improving therapeutic efficacy and reducing ulcerogenicity of meloxicam on oral administrationJ Biomed Nanotechnol2011759059721870464